The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
Part II. Standardization of the neuropathologic assessment of Alzheimer's disease
Abstract
The Neuropathology Task Force of the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) has developed a practical and standardized neuropathology protocol for the postmortem assessment of dementia and control subjects. The protocol provides neuropathologic definitions of such terms as “definite Alzheimer's disease” (AD), “probable AD,” “possible AD,” and “normal brain” to indicate levels of diagnostic certainty, reduce subjective interpretation, and assure common language. To pretest the protocol, neuropathologists from 15 participating centers entered information on autopsy brains from 142 demented patients clinically diagnosed as probable AD and on eight nondemented patients. Eighty-four percent of the dementia cases fulfilled CERAD neuropathologic criteria for definite AD. As increasingly large numbers of prospectively studied dementia and control subjects are autopsied, the CERAD neuropathology protocol will help to refine diagnostic criteria, assess overlapping pathology, and lead to a better understanding of early subclinical changes of AD and normal aging.
Get full access to this article
View all available purchase options and get full access to this article.
Information & Authors
Information
Published In
Copyright
© 1991 by the American Academy of Neurology.
Publication History
Published online: April 1, 1991
Published in print: April 1991
Authors
Metrics & Citations
Metrics
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
Cited By
- Downregulation of Dickkopf-3, a Wnt antagonist elevated in Alzheimer’s disease, restores synapse integrity and memory in a disease mouse model, eLife, 12, (2024).https://doi.org/10.7554/eLife.89453.3
- Downregulation of Dickkopf-3, a Wnt antagonist elevated in Alzheimer’s disease, restores synapse integrity and memory in a disease mouse model, eLife, 12, (2024).https://doi.org/10.7554/eLife.89453
- Two decades of [11C]PiB synthesis, 2003-2023: a review, American Journal of Nuclear Medicine and Molecular Imaging, 14, 1, (48-62), (2024).https://doi.org/10.62347/ADSK6584
- Late-Life Blood Pressure and Cerebral Amyloid Angiopathy: Findings from the U.S. National Alzheimer’s Coordinating Center Uniform Dataset, Neurology International, 16, 4, (821-832), (2024).https://doi.org/10.3390/neurolint16040061
- Ageing-Related Neurodegeneration and Cognitive Decline, International Journal of Molecular Sciences, 25, 7, (4065), (2024).https://doi.org/10.3390/ijms25074065
- Correlation of Presynaptic and Postsynaptic Proteins with Pathology in Alzheimer’s Disease, International Journal of Molecular Sciences, 25, 6, (3130), (2024).https://doi.org/10.3390/ijms25063130
- The Relationship between p-tau217, p-tau231, and p-tau205 in the Human Brain Is Affected by the Cellular Environment and Alzheimer’s Disease Pathology, Cells, 13, 4, (331), (2024).https://doi.org/10.3390/cells13040331
- Hyperspectral Retinal Imaging as a Non-Invasive Marker to Determine Brain Amyloid Status, Journal of Alzheimer's Disease, 100, s1, (S131-S152), (2024).https://doi.org/10.3233/JAD-240631
- Amyloid-β Pathology Is the Common Nominator Proteinopathy of the Primate Brain Aging, Journal of Alzheimer's Disease, 100, s1, (S153-S164), (2024).https://doi.org/10.3233/JAD-240389
- The Association Between Neuropathological Lesions and Body Mass Index Is Independent of Cognitive Abilities, Journal of Alzheimer's Disease, (1-13), (2024).https://doi.org/10.3233/JAD-231366
- See more
Loading...
View Options
Get Access
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.
If you need immediate support or to place an order, please call or email customer service:
- 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
- 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
- [email protected]
We appreciate your patience during this time and apologize for any inconvenience.